Argus Research analyst Kevin Heal upgrades Nasdaq (NASDAQ:NDAQ) from Hold to Buy and announces $200 price target.
Argus Research Upgrades Nasdaq to Buy, Announces $200 Price Target
Argus Research analyst Kevin Heal upgrades Nasdaq (NASDAQ:NDAQ) from Hold to Buy and announces $200 price target.